Shares of MetLife, Inc. (NYSE:MET – Get Free Report) have received an average rating of “Moderate Buy” from the fourteen ratings firms that are presently covering the company, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating on the company. The average 12-month price target among brokerages that have issued a report on the stock in the last year is $95.1538.
Several research firms have recently weighed in on MET. Barclays raised their price objective on MetLife from $89.00 to $93.00 and gave the stock an “overweight” rating in a research note on Thursday, May 7th. Wall Street Zen lowered MetLife from a “buy” rating to a “hold” rating in a research note on Saturday, May 9th. Wells Fargo & Company raised their price objective on MetLife from $90.00 to $95.00 and gave the stock an “overweight” rating in a research note on Tuesday, May 12th. Bank of America reduced their price objective on MetLife from $103.00 to $99.00 and set a “buy” rating for the company in a research note on Tuesday, April 14th. Finally, Evercore set a $96.00 price objective on MetLife in a research note on Thursday, April 9th.
View Our Latest Analysis on MET
MetLife Stock Performance
MetLife (NYSE:MET – Get Free Report) last released its quarterly earnings data on Wednesday, May 6th. The financial services provider reported $2.42 earnings per share for the quarter, topping the consensus estimate of $2.27 by $0.15. The business had revenue of $14.18 billion during the quarter, compared to analyst estimates of $19.49 billion. MetLife had a return on equity of 22.60% and a net margin of 4.66%.The company’s revenue was up 2.7% compared to the same quarter last year. During the same period last year, the company posted $1.96 EPS. Research analysts forecast that MetLife will post 9.94 EPS for the current fiscal year.
MetLife Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 9th. Stockholders of record on Tuesday, May 12th will be paid a dividend of $0.5925 per share. The ex-dividend date of this dividend is Tuesday, May 12th. This represents a $2.37 annualized dividend and a dividend yield of 2.8%. This is a boost from MetLife’s previous quarterly dividend of $0.57. MetLife’s dividend payout ratio is 45.93%.
Institutional Trading of MetLife
Hedge funds have recently modified their holdings of the business. Activest Wealth Management lifted its holdings in shares of MetLife by 205.8% in the fourth quarter. Activest Wealth Management now owns 315 shares of the financial services provider’s stock valued at $25,000 after purchasing an additional 212 shares in the last quarter. Vermillion & White Wealth Management Group LLC lifted its holdings in shares of MetLife by 790.0% in the third quarter. Vermillion & White Wealth Management Group LLC now owns 356 shares of the financial services provider’s stock valued at $29,000 after purchasing an additional 316 shares in the last quarter. Sound Income Strategies LLC lifted its holdings in shares of MetLife by 58.9% in the fourth quarter. Sound Income Strategies LLC now owns 383 shares of the financial services provider’s stock valued at $29,000 after purchasing an additional 142 shares in the last quarter. Garton & Associates Financial Advisors LLC purchased a new stake in shares of MetLife in the fourth quarter valued at $30,000. Finally, Gunpowder Capital Management LLC dba Oliver Wealth Management purchased a new stake in shares of MetLife in the fourth quarter valued at $31,000. Hedge funds and other institutional investors own 94.99% of the company’s stock.
MetLife Company Profile
MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.
In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.
Read More
- Five stocks we like better than MetLife
- SpaceX IPO: Opportunity? Or the Ultimate Hype Trade?
- CAVA Group’s Stock Looks Delicious After Strong Earnings
- Lowe’s Finds Support at $215 After Q1 Earnings Sell-Off
- Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.
